HeartBeam Receives FDA Breakthrough Device Designation for Heart Attack Assessment

Go back to HeartBeam Receives FDA Breakthrough Device Designation for Heart Attack Assessment
BIOTELEMETRY (NASDAQ: BEAT) Delayed: 0.76 +0.33 (76.74%)
Previous Close $0.43    52 Week High $21.68 
Open $0.75    52 Week Low $8.74 
Day High $0.94    P/E N/A 
Day Low $0.66    EPS $-0.46 
Volume 201,850,034